Federal Register
Notices > Importers >
United States Pharmacopeial Convention
FR Doc E8-3178 [Federal Register: February 21, 2008 (Volume 73, Number 35)]
[Notices] [Page 9591-9592] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21fe08-94]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall, prior to issuing a registration
under this section to a bulk manufacturer of a controlled substance in schedule
I or II, and prior to issuing a registration under 21
U.S.C. 952(a)(2) authorizing the importation of such a substance, provide
manufacturers holding registrations for the bulk manufacture of the substance an
opportunity for a hearing.
Therefore, in accordance with Title 21 Code of Federal Regulations (CFR),
1301.34(a), this is notice that on September 18, 2007, United States
Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852,
made application to the Drug Enforcement Administration (DEA) to be registered
as an importer of the basic classes of controlled substances listed in schedule
I and II:
Drug
|
Schedule
|
Cathinone (1235)
|
I
|
Methaqualone (2565)
|
I
|
Lysergic acid diethylamide (7315)
|
I
|
Marihuana (7360)
|
I
|
Tetrahydrocannabinols (7370)
|
I
|
4-Methyl-2,5-dimethoxyamphetamine (7395)
|
I
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
Codeine-n-oxide (9053)
|
I
|
Heroin (9200)
|
I
|
Amphetamine (1100)
|
II
|
Methamphetamine (1105)
|
II
|
Phenmetrazine (1631)
|
II
|
Methylphenidate (1724)
|
II
|
Amobarbital (2125)
|
II
|
Pentobarbital (2270)
|
II
|
Secobarbital (2315)
|
II
|
Glutethimide (2550)
|
II
|
Phencyclidine (7471)
|
II
|
Alphaprodine (9010)
|
II
|
Anileridine (9020)
|
II
|
Cocaine (9041)
|
II
|
Codeine (9050)
|
II
|
Dihydrocodeine (9120)
|
II
|
Oxycodone (9143)
|
II
|
Hydromorphone (9150)
|
II
|
Diphenoxylate (9170)
|
II
|
Hydrocodone (9193)
|
II
|
Levorphanol (9220)
|
II
|
Meperidine (9230)
|
II
|
Methadone (9250)
|
II
|
Dextropropoxyphene, bulk (non-dosage forms)(9273)
|
II
|
Morphine (9300)
|
II
|
Thebaine (9333)
|
II
|
Oxymorphone (9652)
|
II
|
Noroxymorphone (9668)
|
II
|
Alfentanil (9737)
|
II
|
Sufentanil (9740)
|
II
|
Fentanyl (9801)
|
II
|
The company plans to import reference standards for sale to researchers and
analytical labs.
Any bulk manufacturer who is presently, or is applying to be, registered with
DEA to manufacture such basic classes of controlled substances may file comments
or objections to the issuance of the proposed registration and may, at the same
time, file a written request for a hearing on such application pursuant to 21
CFR 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections being sent via regular mail should be
addressed, in quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), Washington, DC 20537,
or any being sent via express mail should be sent to Drug Enforcement
Administration, Office of Diversion Control, Federal Register Representative (ODL),
8701 Morrissette Drive, Springfield, VA. 22152; and must be filed no later than
March 24, 2008.
This procedure is to be conducted simultaneously with, and independent of,
the procedures described in 21
CFR 1301.34(b), (c), (d), (e) and (f). As noted in a previous notice
published in the Federal Register on September 23, 1975, (40 FR 43745-46), all
applicants for registration to import a basic class of any controlled substances
in schedule I or II are, and will continue to be, required to demonstrate to the
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement
Administration, that the requirements for such registration pursuant to 21
U.S.C. 958(a); 21
U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: February 12, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-3178 Filed 2-20-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|